Rajangam Kanyainsider trades

In SEC Form 4 filings, Rajangam Kanya is listed as Pres. & Chief Med. & Dev. Off. of Senti Biosciences Holdings, Inc. (SNTI). Rajangam Kanya reported no open-market purchases or sales in the last 90 days. The latest Form 4 transaction on record was filed on Oct 23.

Companies and roles

Company	Role	Transactions	Last filed
SNTISenti Biosciences Holdings, Inc.	Pres. & Chief Med. & Dev. Off.	1	Oct 23

Cluster buys

No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).

Form 4 historysince 2026-10-23

Company	Traded	Filed	Type	Shares	Price	Value	Owned after	10b5-1 plan	Filing
SNTISenti Biosciences Holdings, Inc.	Oct 21	Oct 23	F	19,953	$0.00	$0	54,890	No	Form 4

Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.